GlassScriptPhysician profile
Manpreet Kaur
NPI 1457139735
$666.77
in general payments reported to CMS, 2019-2025
12 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $140 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $177.50 | 2024-2025 | Zepbound, Mounjaro, Kisunla |
| Exact Sciences Corporation | $175.54 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $118.99 | 2025 | Rexulti |
| Mayne Pharma Commercial LLC | $46.79 | 2025 | |
| Aimmune Therapeutics, INC. | $25.11 | 2025 | Zenpep |
| Dexcom, INC. | $21.06 | 2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.98 | 2025 | Xifaxan |
| Novo Nordisk INC | $18.05 | 2025 | Ozempic, Rybelsus |
| Scilex Pharmaceuticals INC. | $17.22 | 2024 | |
| Pfizer INC. | $16.61 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.93 | 2024 | Farxiga |
| Medtronic, INC. | $14.99 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.